| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
15,630,000 |
| Market
Cap: |
44.86(M) |
| Last
Volume: |
52,352 |
Avg
Vol: |
76,686 |
| 52
Week Range: |
$1.33 - $3.53 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Certain of Co.'s laser products are powered by its proprietary MicroPulse™ technology. Co. provides three product categories: laser consoles; delivery devices which are optical-mechanical products that mount to ophthalmologist's diagnostic equipment and transmit the laser; and single-use disposable probes that transmit the laser light to a targeted region inside the eye.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$6,200 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dizon Romeo R |
Principal Accounting Officer |
– – – |
2018-03-13 |
4 |
S |
$5.86 |
$16,444 |
D/D |
(2,806) |
22,483 |
|
- |
|
| Dizon Romeo R |
Principal Accounting Officer |
– – – |
2018-01-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,383) |
28,100 |
|
- |
|
| Moore William M |
Chairman and CEO |
• • – |
2017-12-12 |
4 |
B |
$7.84 |
$39,200 |
I/I |
5,000 |
83,944 |
2.66 |
- |
|
| Blueline Catalyst Fund Ix, L.p. |
10% Owner |
– – • |
2017-11-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(267,631) |
1,138,862 |
|
- |
|
| Marcellino George R |
Director |
– • – |
2017-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
30,590 |
|
- |
|
| Moore William M |
Chairman and CEO |
• • – |
2017-09-15 |
4 |
B |
$9.42 |
$16,956 |
D/D |
1,800 |
372,434 |
2.81 |
- |
|
| Blueline Partners Ii, Llc |
10% Owner |
– – • |
2017-08-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,195) |
1,406,493 |
|
- |
|
| Moore William M |
Chairman and CEO |
• • – |
2017-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,703 |
370,634 |
|
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-25 |
4 |
B |
$8.67 |
$2,045 |
D/D |
236 |
1,344,720 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-22 |
4 |
B |
$8.42 |
$4,212 |
D/D |
500 |
1,344,484 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-16 |
4 |
B |
$8.40 |
$18,992 |
D/D |
2,260 |
1,343,984 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-15 |
4 |
B |
$8.55 |
$4,743 |
D/D |
555 |
1,341,724 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-11 |
4 |
B |
$8.48 |
$45,475 |
D/D |
5,365 |
1,341,169 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-10 |
4 |
B |
$8.46 |
$24,130 |
D/D |
2,852 |
1,335,804 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-09 |
4 |
B |
$8.60 |
$83,632 |
D/D |
9,730 |
1,332,952 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-08 |
4 |
B |
$8.18 |
$107,872 |
D/D |
13,185 |
1,323,222 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-07 |
4 |
B |
$8.23 |
$4,937 |
D/D |
600 |
1,310,037 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-04 |
4 |
B |
$8.18 |
$134,149 |
D/D |
16,402 |
1,309,437 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-03 |
4 |
B |
$8.67 |
$17,681 |
D/D |
2,040 |
1,293,035 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-02 |
4 |
B |
$8.76 |
$41,025 |
D/D |
4,685 |
1,290,995 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-08-01 |
4 |
B |
$9.14 |
$73,601 |
D/D |
8,055 |
1,286,310 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-07-31 |
4 |
B |
$9.45 |
$48,521 |
D/D |
5,137 |
1,278,255 |
2.37 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-07-28 |
4 |
B |
$9.50 |
$82,033 |
D/D |
8,633 |
1,273,118 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-07-27 |
4 |
B |
$9.47 |
$70,464 |
D/D |
7,442 |
1,264,485 |
2.45 |
- |
|
| Acuta Capital Fund, Lp |
10% Owner |
– – • |
2017-07-26 |
4 |
B |
$9.62 |
$42,477 |
D/D |
4,415 |
1,257,043 |
2.37 |
- |
|
593 Records found
|
|
Page 6 of 24 |
|
|
0.09 (3.04%) 
